Binbin Tang

Dr. Binbin Tang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in World Neurosurgery
Verified
Journal Article
Open access
BTBinbin Tang
Binbin Tang
HZHanbing Zeng
Hanbing Zeng
SHShengjia Hu
Shengjia Hu
KLKang Liu
Kang Liu
LWLianguo Wu
Lianguo Wu
XSXiaolin Shi
Xiaolin Shi
This study was designed to help elucidate the benefits and advantages of vertebroplasty combined with zoledronic acid (ZOL) versus vertebroplasty alone, to provide clinical recommendations for the treatment of osteoporotic vertebral compression fractures (OVCFs) considering the current best-available evidence. We comprehensively searched PubMed, Embase, Web of Science, and the Cochrane Library and performed a systematic review and cumulative meta-analysis of all randomized controlled trials and retrospective comparative studies assessing these important indexes of 2 methods using Review Manager 5.4. Four randomized controlled trials and 4 retrospective studies including 2335 cases were identified. Vertebroplasty combined with ZOL was associated with benefits from decreased pain (weighted mean difference [WMD] -0.43; 95% confidence interval [CI] -0.59 to -0.27; P < 0.05), increased function (WMD -4.94; 95% CI -6.13 to -3.75; P < 0.05), increased BMD of the vertebral body(WMD 0.85; 95% CI 0.30-1.40; P < 0.05) and of the proximal femoral neck (WMD 0.14; 95% CI 0.08-0.21; P < 0.05), fewer markers of bone metabolism (N-terminal molecular fragment: WMD -4.82; 95% CI -6.08 to -3.55; P < 0.05; procollagen type I N-terminal propeptide: WMD -17.31; 95% CI -18.04 to -16.58; P < 0.05; beta collagen degradation product: WMD -0.27; 95% CI -0.35 to -0.19; P < 0.05), and lower rate of refracture (1.54% and 12.6%; odds ratio 0.17; 95% CI 0.08-0.36; P < 0.05). Patients in the vertebroplasty combined with ZOL group had greater vertebral body height (WMD 2.17; 95% CI 0.72-3.62; P < 0.05) than in the vertebroplasty group, but no differences on Cobb angle were observed (WMD -1.18; 95% CI -2.47 to 0.10; P > 0.05). Vertebroplasty combined with ZOL was superior to vertebroplasty alone in terms of BMD, bone metabolism makers, refracture rate, pain and function.

23 March 2022 in Pharmacological Research - Modern Chinese Medicine
Verified
Journal Article
Open access
BTBinbin Tang
Binbin Tang
YYYifeng Yuan
Yifeng Yuan
SWShen Wang
Shen Wang
SLShaohua Li
Shaohua Li
SKShifa Kang
Shifa Kang
XSXiaolin Shi
Xiaolin Shi

4 July 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
BTBinbin Tang
Binbin Tang
SHShengjia Hu
Shengjia Hu
YYYifeng Yuan
Yifeng Yuan
HZHang Zhou
Hang Zhou
XSXiaolin Shi
Xiaolin Shi
Objective: This study aimed to evaluate the efficacy and safety of vertebroplasty versus posterior pedicle screw fixation combined with vertebroplasty in treating stage III Kummell’s disease without neurological deficits. Method: A systematic literature search was conducted across six databases. A meta-analysis of prospective and retrospective studies meeting the inclusion criteria was conducted using Review Manager 5.4.1. Results: Eight studies (one prospective, one randomized control trial, and six retrospective) involving 409 patients were included. Vertebroplasty demonstrated advantages over posterior pedicle screw + vertebroplasty in operative time (weighted mean difference: −83.22 min; 95% confidence interval: −97.70 to −68.73; p   <   0.05), blood loss (weighted mean difference: −158.65 mL; 95% confidence interval: −219.99 to −97.31; p   <   0.05), and hospital stay (weighted mean difference: −5.64 days; 95% confidence interval: −7.36 to −3.92; p   <   0.05). No significant differences were observed in Cobb’s angle (weighted mean difference: 1.28°; 95% confidence interval: −0.21 to 2.78; p   >   0.05), relative anterior vertebral height (weighted mean difference: 2.98%; 95% confidence interval: −4.15 to 10.11; p   >   0.05), cement leakage (13.2% vs. 8.5%; odds ratios: 1.67; 95% confidence interval: 0.86–3.24; p   >   0.05), or wound infection (0% vs. 4.88%; odds ratios: 0.28; 95% confidence interval: 0.07–1.15; p   >   0.05). Conclusion: Both vertebroplasty and posterior pedicle screw + vertebroplasty are effective for treating stage III Kummell’s disease without neurological deficits. Vertebroplasty offers superior perioperative outcomes with reduced surgical trauma and hospital stay. PROSPERO registration number: CRD420251031065.

9 March 2021 in Research Square
Verified
Preprint
Open access
PDF file
BTBinbin Tang
Binbin Tang
KLKang Liu
Kang Liu
LWLianguo Wu
Lianguo Wu
XSXiaolin Shi
Xiaolin Shi
Purpose Insignificant pain relief (IPR) in short period after vertebroplasty is common, which often disturb doctors and affect patients Therefore, we reviewed systematically relative articles and attempted to get meaningful evidence on factors and strategies for IPR.Methods PubMed, Web of Science, Embase, CNKI, WanFang, and VIP were searched for literatures treating the osteoporotic vertebral compression fractures (OVCFs) with vertebroplasty and assessing the clinical efficacy.Results 817 references were electronically retrieved, 81 full-text papers were screened and 41 studies were included. Twenty-two trials presented factors on IPR, mainly including bone cement related, operation related and patient-related factors. Nineteen studies showed strategies on residual pain, including improving osteoporosis, reforming surgical operation and add other therapies. 16 prospective, 20 retrospective and 5 meta-analyses consisted the systematic review. The date from included studies point to different results, with less risk of bias, were needed to clarify the factors and strategies for residual pain.Conclusions Bone cement distribution and operation error are highly related to the post-vertebroplasty residual pain. Many therapeutic methods could improve pain and rehabilitate function but lacking more high-level evidence due to the insufficient trails.

5 December 2025 in Medicine
Verified
Journal Article
Open access
BTBinbin Tang
Binbin Tang
CCChen Chen
Chen Chen
HZHan Zhang
Han Zhang
JFJunwei Feng
Junwei Feng
BWBing Wu
Bing Wu
LDLiqiang Dong
Liqiang Dong
Rationale: Delayed cerebrospinal fluid (CSF) leakage after lumbar interbody fusion are scarce. Known causes include severe spinal canal stenosis and iatrogenic factors. This case presents a unique etiology, highlighting the importance of timely management. Prediction and prevention of postoperative complications is crucial. Patient concerns: We report a 37-year-old woman had recurrent low back pain and radiating right lower extremity pain for 2 years, which had exacerbated over the past week. Imaging revealed mild L5 spondylolisthesis, a free fragment of the L5-S1 lumbar disc, bilateral L5 pars defects (spondylolysis), and floating L5 lamina. Treatment involved L5 right laminectomy and L5-S1 lumbar interbody fusion. On postoperative day 6, the patient developed headache and bulging at the incision site. Diagnoses: Combined with analysis of the aspirated fluid, magnetic resonance imaging indications and patient’s symptoms, a diagnosis of delayed CSF leak was made. Interventions: Resection of the remaining and floating L5 left lamina and direct suturation were performed for dural tear repair followed by postoperative drainage tube placement. Outcomes: The patient was discharged with successful recovery 2 weeks after the second surgery. Follow-up lumbar magnetic resonance imaging confirmed resolution of the CSF leak and satisfactory recovery. Lessons: In lumbar pathologies with unique anatomy like a floating lamina, vigilance for delayed CSF leak is crucial. Meticulous preoperative imaging review and adaptable surgical strategies beyond conventional approaches are essential for preventing recurrence.